April 10, 2022

“I Wanted To Be In Control. Wanted The Pain To Go Away Without The Psychoactive Part”

SyqeAir patients talk about the treatment utilizing the medical inhaler. From the moment the doctors suggested treatment using medical cannabis till now.

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

28/04/2021

Studies show the low-dose, smokeless device is effective at treating chronic pain without psychoactive effects.

Novachem offers metered-dosing inhaler to Australian patients

21/12/2022

A metered-dose inhaler is being distributed by Novachem in Australia. Syqe® Medical, the Israeli MedTech company behind the technology claims it will “revolutionize” the delivery of medicinal cannabis.

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler

23/04/2023

Israeli startup Syqe® says it’s solved the problem of unpredictable and inconsistent medical cannabis treatment with the SyqeAir Inhaler and Cartridges that deliver the same dose of cannabis every time.

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.

Day: April 10, 2022

“I Wanted To Be In Control. Wanted The Pain To Go Away Without The Psychoactive Part”

Related Posts

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

Novachem offers metered-dosing inhaler to Australian patients

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler